Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin.

MLA

Strazzulla, Alessio, et al. “Evolution of Haemostatic Parameters and Risk of Bleeding during Treatment with Cefazolin.” European Journal of Clinical Microbiology & Infectious Diseases, vol. 38, no. 1, Jan. 2019, pp. 177–83. EBSCOhost, https://doi.org/10.1007/s10096-018-3412-6.

APA

Strazzulla, A., Chakvetadze, C., De Pontfarcy, A., Flateau, C., Danneels, P., Belfeki, N., Diamantis, S., Picque, M., Cassard, B., & Hernandez, F. (2019). Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin. European Journal of Clinical Microbiology & Infectious Diseases, 38(1), 177–183. https://doi.org/10.1007/s10096-018-3412-6

Chicago

Strazzulla, Alessio, Catherine Chakvetadze, Astrid De Pontfarcy, Clara Flateau, Pierre Danneels, Nabil Belfeki, Sylvain Diamantis, Marie Picque, Bruno Cassard, and Fabien Hernandez. 2019. “Evolution of Haemostatic Parameters and Risk of Bleeding during Treatment with Cefazolin.” European Journal of Clinical Microbiology & Infectious Diseases 38 (1): 177–83. doi:10.1007/s10096-018-3412-6.